Publication | Closed Access
High Expression of MYL9 Indicates Poor Clinical Prognosis of Epithelial Ovarian Cancer
28
Citations
19
References
2021
Year
MYL9 is upregulated in EOC and may serve as a useful patent of prognostic biomarker in EOC, and it may demonstrate an important value for the clinical treatment and supervision of patients with EOC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1